Strategic Wealth Partners, Ltd. Viatris Inc Transaction History

Strategic Wealth Partners, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	SELL	$11.27 - $13.53 $288,162 - $345,948	-25,569 Closed	0 $0
Q4 2023 May 20, 2024	SELL	$8.77 - $10.85 $1.31 Million - $1.62 Million	-149,029 Reduced 85.36%	25,569 $276,000
Q3 2023 May 20, 2024	SELL	$9.59 - $11.35 $248,975 - $294,668	-25,962 Reduced 12.94%	174,598 $1.72 Million
Q2 2023 May 20, 2024	SELL	$9.02 - $10.29 $21,575 - $24,613	-2,392 Reduced 1.18%	200,560 $2 Million
Q1 2023 Apr 24, 2023	SELL	$9.2 - $12.26 $126,849 - $169,040	-13,788 Reduced 6.36%	202,952 $1.95 Million
Q4 2022 Apr 24, 2023	SELL	$8.72 - $11.56 $121,722 - $161,366	-13,959 Reduced 6.05%	216,740 $2.41 Million
Q3 2022 Apr 24, 2023	SELL	$8.48 - $11.13 $84 - $111	-10 Reduced -0.0%	230,699 $1.97 Million
Q2 2022 Aug 22, 2022	SELL	$9.95 - $12.27 $65,182 - $80,380	-6,551 Reduced 2.76%	230,709 $2.42 Million
Q1 2022 May 19, 2022	BUY	$9.81 - $15.4 $2.33 Million - $3.65 Million	237,260 New	237,260 $2.58 Million

1,098

970M

2.63M

2.15M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.9B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.